Nobivac Parvo Live vet. injektiokuiva-aine ja liuotin suspensiota varten
Nobivac Parvo Live vet. injektiokuiva-aine ja liuotin suspensiota varten
Not authorised
- Canine parvovirus, strain CPV 154, Live
Product identification
Medicine name:
Nobivac Parvo Live vet. injektiokuiva-aine ja liuotin suspensiota varten
Active substance:
- Canine parvovirus, strain CPV 154, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parvovirus, strain CPV 154, Live7.00/log10 50% tissue culture infectious dose1.00dose
Pharmaceutical form:
-
Powder and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Finland
Package description:
- Available only in Finnish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- FIMEA
Authorisation number:
- 13501
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 1/02/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 1/02/2022
